de Serres F J, Blanco I, Fernández-Bustillo E
National Institute of Environmental Health Sciences, PO Box 12233, Center for the Evaluation of Risks to Human Reproduction National Toxicology Program Research Triangle Park NC 27709-2233 USA.
Eur Respir J. 2006 Dec;28(6):1091-9. doi: 10.1183/09031936.00029806. Epub 2006 Sep 27.
The current study focuses on updating estimates of the numbers of individuals carrying the two most common deficiency alleles, protease inhibitor (PI)S and PIZ, for alpha1-antitrypsin deficiency (AT-D) in 20 Asian countries. A total of 170 cohorts with 31,177 individuals were selected from 20 Asian countries. The total AT-D populations in the countries selected were: 7,264 ZZ; 36,754 SZ; 6,672,479 MZ; 46,492 SS; and 16,881,108 MS. Marked differences among the Asian countries and regions were also found for the prevalence of the deficiency alleles PIS and PIZ. These numbers demonstrate that AT-D is not just a genetic disease that affects smaller numbers than various countries, for example, in Europe. There were marked differences between the prevalence of the PIS and PIZ deficiency alleles among these 20 Asian countries as well as among the countries within a given geographic region in Asia. The largest numbers of ZZ phenotypes (3,000-14,000) were in Afghanistan, Pakistan, Saudi Arabia and Thailand; with <1,700 in each of the remaining countries.
当前的研究聚焦于更新20个亚洲国家中携带α1-抗胰蛋白酶缺乏症(AT-D)两种最常见缺陷等位基因,即蛋白酶抑制剂(PI)S和PIZ的个体数量估计值。从20个亚洲国家选取了总共170个队列,包含31177名个体。所选国家的AT-D总人口数分别为:7264名ZZ型;36754名SZ型;6672479名MZ型;46492名SS型;以及16881108名MS型。在亚洲国家和地区之间,缺陷等位基因PIS和PIZ的患病率也存在显著差异。这些数字表明,AT-D并非仅仅是一种患病人数比欧洲等各国少的遗传病。在这20个亚洲国家之间以及亚洲特定地理区域内的国家之间,PIS和PIZ缺陷等位基因的患病率存在显著差异。ZZ表型个体数量最多(3000 - 14000)的国家是阿富汗、巴基斯坦、沙特阿拉伯和泰国;其余国家每个国家的ZZ表型个体数量均少于1700。